Cargando…

Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow

OBJECTIVE: The present study was undertaken to determine the efficacy of coadministration of fingolimod with alteplase in acute ischemic stroke patients in a delayed time window. METHODS: This was a prospective, randomized, open‐label, blinded endpoint clinical trial, enrolling patients with interna...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, De‐Cai, Shi, Kaibin, Zhu, Zilong, Yao, Jia, Yang, Xiaoxia, Su, Lei, Zhang, Sheng, Zhang, Meixia, Gonzales, Rayna J., Liu, Qiang, Huang, DeRen, Waters, Michael F., Sheth, Kevin N., Ducruet, Andrew F., Fu, Ying, Lou, Min, Shi, Fu‐Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282815/
https://www.ncbi.nlm.nih.gov/pubmed/30295338
http://dx.doi.org/10.1002/ana.25352
_version_ 1783379071613272064
author Tian, De‐Cai
Shi, Kaibin
Zhu, Zilong
Yao, Jia
Yang, Xiaoxia
Su, Lei
Zhang, Sheng
Zhang, Meixia
Gonzales, Rayna J.
Liu, Qiang
Huang, DeRen
Waters, Michael F.
Sheth, Kevin N.
Ducruet, Andrew F.
Fu, Ying
Lou, Min
Shi, Fu‐Dong
author_facet Tian, De‐Cai
Shi, Kaibin
Zhu, Zilong
Yao, Jia
Yang, Xiaoxia
Su, Lei
Zhang, Sheng
Zhang, Meixia
Gonzales, Rayna J.
Liu, Qiang
Huang, DeRen
Waters, Michael F.
Sheth, Kevin N.
Ducruet, Andrew F.
Fu, Ying
Lou, Min
Shi, Fu‐Dong
author_sort Tian, De‐Cai
collection PubMed
description OBJECTIVE: The present study was undertaken to determine the efficacy of coadministration of fingolimod with alteplase in acute ischemic stroke patients in a delayed time window. METHODS: This was a prospective, randomized, open‐label, blinded endpoint clinical trial, enrolling patients with internal carotid artery or middle cerebral artery proximal occlusion within 4.5 to 6 hours from symptom onset. Patients were randomly assigned to receive alteplase alone or alteplase with fingolimod. All patients underwent pretreatment and 24‐hour noncontrast computed tomography (CT)/perfusion CT/CT angiography. The coprimary endpoints were the decrease of National Institutes of Health Stroke Scale scores over 24 hours and the favorable shift of modified Rankin Scale score (mRS) distribution at day 90. Exploratory outcomes included vessel recanalization, anterograde reperfusion, and retrograde reperfusion of collateral flow. RESULTS: Each treatment group included 23 patients. Compared with alteplase alone, patients receiving fingolimod plus alteplase exhibited better early clinical improvement at 24 hours and a favorable shift of mRS distribution at day 90. In addition, patients who received fingolimod and alteplase exhibited a greater reduction in the perfusion lesion accompanied by suppressed infarct growth by 24 hours. Fingolimod in conjunction with alteplase significantly improved anterograde reperfusion of downstream territory and prevented the failure of retrograde reperfusion from collateral circulation. INTERPRETATION: Fingolimod may enhance the efficacy of alteplase administration in the 4.5‐ to 6‐hour time window in patients with a proximal cerebral arterial occlusion and salvageable penumbral tissue by promoting both anterograde reperfusion and retrograde collateral flow. These findings are instructive for the design of future trials of recanalization therapies in extended time windows. Ann Neurol 2018;84:725–736
format Online
Article
Text
id pubmed-6282815
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62828152018-12-11 Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow Tian, De‐Cai Shi, Kaibin Zhu, Zilong Yao, Jia Yang, Xiaoxia Su, Lei Zhang, Sheng Zhang, Meixia Gonzales, Rayna J. Liu, Qiang Huang, DeRen Waters, Michael F. Sheth, Kevin N. Ducruet, Andrew F. Fu, Ying Lou, Min Shi, Fu‐Dong Ann Neurol Research Articles OBJECTIVE: The present study was undertaken to determine the efficacy of coadministration of fingolimod with alteplase in acute ischemic stroke patients in a delayed time window. METHODS: This was a prospective, randomized, open‐label, blinded endpoint clinical trial, enrolling patients with internal carotid artery or middle cerebral artery proximal occlusion within 4.5 to 6 hours from symptom onset. Patients were randomly assigned to receive alteplase alone or alteplase with fingolimod. All patients underwent pretreatment and 24‐hour noncontrast computed tomography (CT)/perfusion CT/CT angiography. The coprimary endpoints were the decrease of National Institutes of Health Stroke Scale scores over 24 hours and the favorable shift of modified Rankin Scale score (mRS) distribution at day 90. Exploratory outcomes included vessel recanalization, anterograde reperfusion, and retrograde reperfusion of collateral flow. RESULTS: Each treatment group included 23 patients. Compared with alteplase alone, patients receiving fingolimod plus alteplase exhibited better early clinical improvement at 24 hours and a favorable shift of mRS distribution at day 90. In addition, patients who received fingolimod and alteplase exhibited a greater reduction in the perfusion lesion accompanied by suppressed infarct growth by 24 hours. Fingolimod in conjunction with alteplase significantly improved anterograde reperfusion of downstream territory and prevented the failure of retrograde reperfusion from collateral circulation. INTERPRETATION: Fingolimod may enhance the efficacy of alteplase administration in the 4.5‐ to 6‐hour time window in patients with a proximal cerebral arterial occlusion and salvageable penumbral tissue by promoting both anterograde reperfusion and retrograde collateral flow. These findings are instructive for the design of future trials of recanalization therapies in extended time windows. Ann Neurol 2018;84:725–736 John Wiley and Sons Inc. 2018-11-02 2018-11 /pmc/articles/PMC6282815/ /pubmed/30295338 http://dx.doi.org/10.1002/ana.25352 Text en © 2018 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Tian, De‐Cai
Shi, Kaibin
Zhu, Zilong
Yao, Jia
Yang, Xiaoxia
Su, Lei
Zhang, Sheng
Zhang, Meixia
Gonzales, Rayna J.
Liu, Qiang
Huang, DeRen
Waters, Michael F.
Sheth, Kevin N.
Ducruet, Andrew F.
Fu, Ying
Lou, Min
Shi, Fu‐Dong
Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
title Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
title_full Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
title_fullStr Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
title_full_unstemmed Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
title_short Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
title_sort fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282815/
https://www.ncbi.nlm.nih.gov/pubmed/30295338
http://dx.doi.org/10.1002/ana.25352
work_keys_str_mv AT tiandecai fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT shikaibin fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT zhuzilong fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT yaojia fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT yangxiaoxia fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT sulei fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT zhangsheng fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT zhangmeixia fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT gonzalesraynaj fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT liuqiang fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT huangderen fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT watersmichaelf fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT shethkevinn fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT ducruetandrewf fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT fuying fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT loumin fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow
AT shifudong fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow